Lv1
18 积分 2023-02-15 加入
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma
29天前
已完结
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China
1个月前
已完结
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant non-small cell lung cancer (NEOTIDE/CTONG2104): phase II trial and correlative genomic analysis in China
2个月前
已完结
Association of HER‐2 overexpression with prognosis in nonsmall cell lung carcinoma: A metaanalysis
2个月前
已完结
Camrelizumab plus nab-paclitaxel and cisplatin as first-line treatment for metastatic triple-negative breast cancer: A prospective, single-arm, open-label phase II trial
3个月前
已完结
Outcomes following microwave ablation of 669 primary and metastatic lung malignancies
4个月前
已完结
Intracerebral efficacy and tolerance of nivolumab in non–small-cell lung cancer patients with brain metastases
4个月前
已完结
Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study
4个月前
已完结
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
4个月前
已完结
皖公网安备34019202002308
